434 related articles for article (PubMed ID: 31916109)
1. Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease.
Stock CJW; De Lauretis A; Visca D; Daccord C; Kokosi M; Kouranos V; Margaritopoulos G; George PM; Molyneaux PL; Nihtyanova S; Chua F; Maher TM; Ong V; Abraham DJ; Denton CP; Wells AU; Wain LV; Renzoni EA
Clin Rheumatol; 2020 Apr; 39(4):1173-1179. PubMed ID: 31916109
[TBL] [Abstract][Full Text] [Related]
2. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887
[TBL] [Abstract][Full Text] [Related]
3. The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms.
Zhao W; Yue X; Liu K; Zheng J; Huang R; Zou J; Riemekasten G; Petersen F; Yu X
Rheumatol Int; 2017 Aug; 37(8):1303-1310. PubMed ID: 28434122
[TBL] [Abstract][Full Text] [Related]
4. BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4.
Dieudé P; Wipff J; Guedj M; Ruiz B; Melchers I; Hachulla E; Riemekasten G; Diot E; Hunzelmann N; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Distler J; Amoura Z; Tarner I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Nov; 60(11):3447-54. PubMed ID: 19877059
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis.
Xu Y; Wang W; Tian Y; Liu J; Yang R
Int J Dermatol; 2016 Apr; 55(4):408-16. PubMed ID: 26712637
[TBL] [Abstract][Full Text] [Related]
6. IRF5 polymorphism predicts prognosis in patients with systemic sclerosis.
Sharif R; Mayes MD; Tan FK; Gorlova OY; Hummers LK; Shah AA; Furst DE; Khanna D; Martin J; Bossini-Castillo L; Gonzalez EB; Ying J; Draeger HT; Agarwal SK; Reveille JD; Arnett FC; Wigley FM; Assassi S
Ann Rheum Dis; 2012 Jul; 71(7):1197-202. PubMed ID: 22440820
[TBL] [Abstract][Full Text] [Related]
7. [The influence of STAT4 rs7574865 (G/T) polymorphism on the risk of clinical and immunological phenotypes of systemic sclerosis in a Russian patient population: Results of a pilot study].
Krylov MY; Ananyeva LP; Koneva ОА; Starovoytova MN; Desinova OV; Ovsyannikova OB; Aleksandrova EN; Novikov AA; Guseva IA; Konovalova NV; Varlamov DA
Ter Arkh; 2017; 89(5):20-25. PubMed ID: 28631694
[TBL] [Abstract][Full Text] [Related]
8. The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis.
Carmona FD; Martin JE; Beretta L; Simeón CP; Carreira PE; Callejas JL; Fernández-Castro M; Sáez-Comet L; Beltrán E; Camps MT; Egurbide MV; ; Airó P; Scorza R; Lunardi C; Hunzelmann N; Riemekasten G; Witte T; Kreuter A; Distler JH; Madhok R; Shiels P; van Laar JM; Fonseca C; Denton C; Herrick A; Worthington J; Schuerwegh AJ; Vonk MC; Voskuyl AE; Radstake TR; Martín J
PLoS One; 2013; 8(1):e54419. PubMed ID: 23372721
[TBL] [Abstract][Full Text] [Related]
9. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858
[TBL] [Abstract][Full Text] [Related]
10. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk.
Abelson AK; Delgado-Vega AM; Kozyrev SV; Sánchez E; Velázquez-Cruz R; Eriksson N; Wojcik J; Linga Reddy MV; Lima G; D'Alfonso S; Migliaresi S; Baca V; Orozco L; Witte T; Ortego-Centeno N; ; Abderrahim H; Pons-Estel BA; Gutiérrez C; Suárez A; González-Escribano MF; Martin J; Alarcón-Riquelme ME
Ann Rheum Dis; 2009 Nov; 68(11):1746-53. PubMed ID: 19019891
[TBL] [Abstract][Full Text] [Related]
11. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis.
Dieudé P; Guedj M; Wipff J; Avouac J; Fajardy I; Diot E; Granel B; Sibilia J; Cabane J; Mouthon L; Cracowski JL; Carpentier PH; Hachulla E; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Jan; 60(1):225-33. PubMed ID: 19116937
[TBL] [Abstract][Full Text] [Related]
12. Gene-gene interactions of IRF5, STAT4, IKZF1 and ETS1 in systemic lupus erythematosus.
Dang J; Shan S; Li J; Zhao H; Xin Q; Liu Y; Bian X; Liu Q
Tissue Antigens; 2014 Jun; 83(6):401-8. PubMed ID: 24697319
[TBL] [Abstract][Full Text] [Related]
13. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.
Dieude P; Dawidowicz K; Guedj M; Legrain Y; Wipff J; Hachulla E; Diot E; Sibilia J; Mouthon L; Cabane J; Amoura Z; Crakowski JL; Carpentier P; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
J Rheumatol; 2010 May; 37(5):987-92. PubMed ID: 20231204
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Systemic Sclerosis-associated Genes in a Turkish Population.
Carmona FD; Onat AM; Fernández-Aranguren T; Serrano-Fernández A; Robledo G; Direskeneli H; Sawalha AH; Yavuz S; Martín J
J Rheumatol; 2016 Jul; 43(7):1376-9. PubMed ID: 27134258
[TBL] [Abstract][Full Text] [Related]
15. Association of the IRF5 SNP rs2004640 with systemic sclerosis in Han Chinese.
Wang J; Yi L; Guo X; Liu M; Li H; Zou H; Gu Y; Tu W; Guo G; Yang L; Lai S; He D; Zhou X
Int J Immunopathol Pharmacol; 2014; 27(4):635-8. PubMed ID: 25572744
[TBL] [Abstract][Full Text] [Related]
16. The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype.
Rueda B; Broen J; Simeon C; Hesselstrand R; Diaz B; Suárez H; Ortego-Centeno N; Riemekasten G; Fonollosa V; Vonk MC; van den Hoogen FH; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Coenen MJ; Airo P; Beretta L; Scorza R; van Laar J; Gonzalez-Escribano MF; Nelson JL; Radstake TR; Martin J
Hum Mol Genet; 2009 Jun; 18(11):2071-7. PubMed ID: 19286670
[TBL] [Abstract][Full Text] [Related]
17. STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population.
Yi L; Wang JC; Guo XJ; Gu YH; Tu WZ; Guo G; Yang L; Xiao R; Yu L; Mayes MD; Assassi S; Jin L; Zou HJ; Zhou XD
Int J Immunopathol Pharmacol; 2013; 26(2):473-478. PubMed ID: 23755762
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines.
Gourh P; Agarwal SK; Divecha D; Assassi S; Paz G; Arora-Singh RK; Reveille JD; Shete S; Mayes MD; Arnett FC; Tan FK
Arthritis Rheum; 2009 Dec; 60(12):3794-806. PubMed ID: 19950257
[TBL] [Abstract][Full Text] [Related]
19. Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung disease.
Odani T; Yasuda S; Ota Y; Fujieda Y; Kon Y; Horita T; Kawaguchi Y; Atsumi T; Yamanaka H; Koike T
Rheumatology (Oxford); 2012 Oct; 51(10):1765-74. PubMed ID: 22723597
[TBL] [Abstract][Full Text] [Related]
20. Unfolding the pathogenesis of scleroderma through genomics and epigenomics.
Tsou PS; Sawalha AH
J Autoimmun; 2017 Sep; 83():73-94. PubMed ID: 28526340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
